表观遗传市场：趋势、机会与竞争分析 [2023-2028]

表观遗传市场趋势与预测

预计到 2028 年，全球表观遗传学市场将达到 36 亿美元，2023 年至 2028 年年复合成长率为 14.5%。该市场的主要促进因素是由于投资、资金筹措和核准的增加而加大表观遗传学研究和开发的配合措施，扩大表观遗传学在推动药物研发发现和开发方面的应用，提高可负担性和可及性，扩大基因组定序的可及性。全球表观遗传学市场的未来前景广阔，为学术和研究机构、製药公司、生物技术公司和委託研究组织 (CRO) 提供了商机。

表观遗传市场洞察

• Lucintel 预计，由于全球对易于使用、经济高效和先进的表观遗传试剂盒和试剂的需求不断增长，试剂盒和试剂在预测期内仍将是最大的细分市场。
• 在这个市场中，由于政府研究机构和大学实验室广泛采用表观遗传产品，学术和研究机构仍将是最大的最终用途部分。
• 由于人们对先进医疗基础设施的认识不断增强、研发支出不断增加以及该地区领先公司的存在，北美在预测期内仍将是最大的地区。

本报告回答了 11 个关键问题：

• Q.1. 细分市场中最有前途和高成长的机会是什么？
• Q.2.哪个细分市场将以更快的速度成长？为什么？
• Q.3.您认为哪些地区未来会出现更快的成长？为什么？
• Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和业务风险是什么？
• Q.5. 这个市场的商业风险和竞争威胁是什么？
• Q.6.这个市场有哪些新趋势？为什么？
• Q.7.市场客户需求有何改变？
• Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
• Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
• Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
• Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球表观遗传学市场：市场动态

• 简介、背景、分类
• 供应链
• 产业促进因素与挑战

第3章2017-2028年市场趋势及预测分析

• 宏观经济趋势（2017-2022）与预测（2023-2028）
• 全球表观遗传学市场趋势（2017-2022）与预测（2023-2028）
• 按产品和服务分類的全球表观遗传学市场
  • 试剂盒和试剂
  • 酵素
  • 乐器及配件
  • 软体
  • 服务
• 按技术分類的全球表观遗传学市场
  • DNA甲基化
  • 组蛋白甲基化
  • 其他的
• 按最终用途行业分類的全球表观遗传学市场
  • 学术研究所
  • 製药和生物技术公司
  • 合约研究组织（CRO）
  • 其他的

第4章2017-2028年分地区市场趋势及预测分析

• 全球表观遗传学市场（按地区）
• 北美表观遗传学市场
• 欧洲表观遗传市场
• 亚太表观遗传学市场
• 其他区域表观遗传市场

第5章竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第6章成长机会与策略分析

• 成长机会分析
  • 全球表观遗传学市场成长机会（按产品和服务划分）
  • 科技驱动的全球表观遗传学市场成长机会
  • 最终用途产业的全球表观遗传学市场成长机会
  • 按地区分類的全球表观遗传学市场成长机会
• 全球表观遗传学市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球表观遗传市场的容量
  • 全球表观遗传学市场的合併、收购与合资企业
  • 认证和许可

第7章主要企业概况

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Trends and Forecast

The future of the global epigenetic market looks promising with opportunities in the academic and research institutes, pharmaceutical companies and biotechnology companies, and contract research organizations (CROs). The global epigenetic market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.5% from 2023 to 2028. The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.

A more than 150-page report is developed to help in your business decisions.

Epigenetic Market by Segment

The study includes trends and forecast for the global epigenetic market by product & service, technology, end use industry, and region as follows:

Epigenetic Market by Product & Service [Shipment Analysis by Value from 2017 to 2028]:

• Kits & Reagents
• Enzymes
• Instruments & Accessories
• Software
• Services

Epigenetic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• DNA Methylation
• Histone Methylation
• Others

Epigenetic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

Epigenetic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Epigenetic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, epigenetic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the epigenetic companies profiled in this report include:

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Insights

• Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Within this market, academics and research institutes will remain the largest end use segment due to the widespread adoption of epigenetic products across government research institutions and university laboratories.
• North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures, and the existence of major companies in this region.

Features of the Global Epigenetic Market

• Market Size Estimates: Epigenetic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Epigenetic market size by various segments, such as by product & service, technology, end use industry, and region in terms of value ($B).
• Regional Analysis: Epigenetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different products & services, technologies, end use industries, and regions for the epigenetic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Epigenetic Market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q.1. What is the epigenetic market size?
• Answer: The global epigenetic market is expected to reach an estimated $3.6 billion by 2028.
• Q.2. What is the growth forecast for epigenetic market?
• Answer: The global epigenetic market is expected to grow with a CAGR of 14.5% from 2023 to 2028
• Q.3. What are the major drivers influencing the growth of the epigenetic market?
• Answer: The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.
• Q4. What are the major segments for epigenetic market?
• Answer: The future of the global epigenetic market looks promising with opportunities in academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).
• Q5. Who are the key epigenetic companies?
• Answer: Some of the key epigenetic companies are as follows:
  • Abcam
  • Active Motiff
  • Hologic
  • F. Hoffmann-La Roche
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Novartis
  • Element Biosciences
  • Dovetail Genomics
• Q6. Which epigenetic market segment will be the largest in future?
• Answer: Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Q7. In epigenetic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures and the existence of major companies in this region.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global epigenetic market by product & service (kits & reagents, enzymes, instruments & accessories, software, and services), technology (DNA methylation, histone methylation, and others), end use industry (academic and research institutes, pharmaceutical companies and biotechnology companies, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Epigenetic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Epigenetic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Epigenetic Market by Product & Service
  • 3.3.1: Kits & Reagents
  • 3.3.2: Enzymes
  • 3.3.3: Instruments & Accessories
  • 3.3.4: Software
  • 3.3.5: Services
• 3.4: Global Epigenetic Market by Technology
  • 3.4.1: DNA Methylation
  • 3.4.2: Histone Methylation
  • 3.4.3: Others
• 3.5: Global Epigenetic Market by End Use Industry
  • 3.5.1: Academic and Research Institutes
  • 3.5.2: Pharmaceutical Companies and Biotechnology Companies
  • 3.5.3: Contract Research Organizations (CROs)
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Epigenetic Market by Region
• 4.2: North American Epigenetic Market
  • 4.2.1: North American Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.2.2: North American Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.3: European Epigenetic Market
  • 4.3.1: European Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.3.2: European Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.4: APAC Epigenetic Market
  • 4.4.1: APAC Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.4.2: APAC Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others
• 4.5: ROW Epigenetic Market
  • 4.5.1: ROW Epigenetic Market by Product & Service: Kits & Reagents, Enzymes, Instruments & Accessories, Software, and Services
  • 4.5.2: ROW Epigenetic Market by End Use Industry: Academic and Research Institutes, Pharmaceutical Companies and Biotechnology Companies, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Epigenetic Market by Product & Service
  • 6.1.2: Growth Opportunities for the Global Epigenetic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Epigenetic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Epigenetic Market by Region
• 6.2: Emerging Trends in the Global Epigenetic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Epigenetic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Epigenetic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abcam
• 7.2: Active Motiff
• 7.3: Hologic
• 7.4: F. Hoffmann-La Roche
• 7.5: Illumina
• 7.6: Qiagen
• 7.7: Thermo Fisher Scientific
• 7.8: Novartis
• 7.9: Element Biosciences
• 7.10: Dovetail Genomics